Victor Ivanovich Nikulin

This inventor holds 8 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Irm LLC, Novartis Ag. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Ivanovich Nikulin. Retrieved from https://idiyas.com/inventor/victor-ivanovich-nikulin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 12.5

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 18(Granted Patents)

Location History:

San Diego, CA (US) (2013)
Carlsbad, CA (US) (2010 - 2021)

Company Filing History:

Years Active: 2010-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11066369 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2021-07-20),

2. 10450273 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2019-10-22),

3. 8575168 - Compounds and compositions as modulators of GPR119 activity (2013-11-05),

4. 8394841 - Compounds and methods for modulating G protein-coupled receptors (2013-03-12),

5. 8334288 - 4-phenoxymethylpiperidines as modulators of GPR119 activity (2012-12-18),

6. 8258156 - Compounds and compositions as modulators of GPR119 activity (2012-09-04),

7. 8153635 - Compounds and compositions as modulators of GPR119 activity (2012-04-10),

8. 7846923 - Compounds and compositions as protein kinase inhbitors (2010-12-07),

Title: Victor Ivanovich Nikulin: Innovator in Pharmaceutical Chemistry

Introduction

Victor Ivanovich Nikulin is a prominent inventor based in Carlsbad, California. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. His work primarily focuses on the development of novel compounds aimed at treating various diseases.

Latest Patents

Among his latest patents, Nikulin has developed N-(pyridin-2-yl)pyridine-sulfonamide derivatives. These compounds are designed to modulate the activity of CFTR, which is crucial in the treatment of cystic fibrosis and related disorders. The invention not only details the compounds' formula but also provides methods for their manufacturing and therapeutic applications. This innovative approach has the potential to significantly impact the management of diseases associated with CFTR dysfunction.

Career Highlights

Throughout his career, Victor Nikulin has worked with notable companies such as Irm LLC and Novartis AG. His experience in these organizations has allowed him to refine his expertise in drug development and innovation. His contributions have been instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Nikulin has collaborated with esteemed colleagues, including Robert Epple and Mihai Azimioara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in pharmaceutical research.

Conclusion

Victor Ivanovich Nikulin stands out as a key figure in the realm of pharmaceutical innovation. His dedication to developing effective treatments for diseases showcases the importance of research and collaboration in advancing healthcare solutions. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.